Basic science breaks through: New therapeutic advances in Parkinson's disease.
Identifieur interne : 000310 ( Main/Exploration ); précédent : 000309; suivant : 000311Basic science breaks through: New therapeutic advances in Parkinson's disease.
Auteurs : Patrik Brundin [États-Unis] ; Graham Atkin [États-Unis] ; Jennifer T. Lamberts [États-Unis]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease and is typically associated with progressive motor dysfunction, although PD patients also exhibit a variety of non-motor symptoms. The neuropathological hallmark of PD is intraneuronal inclusions containing primarily α-Synuclein (α-Syn), and several lines of evidence point to α-Syn as a key contributor to disease progression. Thus, basic research in the field of PD is largely focused on understanding the pathogenic properties of α-Syn. Over the past 2 y, these studies helped to identify several novel therapeutic strategies that have the potential to slow PD progression; such strategies include sequestration of extracellular α-Syn through immunotherapy, reduction of α-Syn multimerization or intracellular toxicity, and attenuation of the neuroinflammatory response. This review describes these and other putative therapeutic strategies, together with the basic science research that led to their identification. The current breadth of novel targets for the treatment of PD warrants cautious optimism in the fight against this devastating disease.
DOI: 10.1002/mds.26332
PubMed: 26177603
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000116
- to stream PubMed, to step Curation: 000116
- to stream PubMed, to step Checkpoint: 000311
- to stream Ncbi, to step Merge: 004402
- to stream Ncbi, to step Curation: 004402
- to stream Ncbi, to step Checkpoint: 004402
- to stream Main, to step Merge: 000310
- to stream Main, to step Curation: 000310
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Basic science breaks through: New therapeutic advances in Parkinson's disease.</title><author><name sortKey="Brundin, Patrik" sort="Brundin, Patrik" uniqKey="Brundin P" first="Patrik" last="Brundin">Patrik Brundin</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Atkin, Graham" sort="Atkin, Graham" uniqKey="Atkin G" first="Graham" last="Atkin">Graham Atkin</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Lamberts, Jennifer T" sort="Lamberts, Jennifer T" uniqKey="Lamberts J" first="Jennifer T" last="Lamberts">Jennifer T. Lamberts</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26177603</idno><idno type="pmid">26177603</idno><idno type="doi">10.1002/mds.26332</idno><idno type="wicri:Area/PubMed/Corpus">000116</idno><idno type="wicri:Area/PubMed/Curation">000116</idno><idno type="wicri:Area/PubMed/Checkpoint">000311</idno><idno type="wicri:Area/Ncbi/Merge">004402</idno><idno type="wicri:Area/Ncbi/Curation">004402</idno><idno type="wicri:Area/Ncbi/Checkpoint">004402</idno><idno type="wicri:Area/Main/Merge">000310</idno><idno type="wicri:Area/Main/Curation">000310</idno><idno type="wicri:Area/Main/Exploration">000310</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Basic science breaks through: New therapeutic advances in Parkinson's disease.</title><author><name sortKey="Brundin, Patrik" sort="Brundin, Patrik" uniqKey="Brundin P" first="Patrik" last="Brundin">Patrik Brundin</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Atkin, Graham" sort="Atkin, Graham" uniqKey="Atkin G" first="Graham" last="Atkin">Graham Atkin</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Lamberts, Jennifer T" sort="Lamberts, Jennifer T" uniqKey="Lamberts J" first="Jennifer T" last="Lamberts">Jennifer T. Lamberts</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Translational Parkinson's Disease Research, Van Andel Research Institute, Grand Rapids, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is the second most common neurodegenerative disease and is typically associated with progressive motor dysfunction, although PD patients also exhibit a variety of non-motor symptoms. The neuropathological hallmark of PD is intraneuronal inclusions containing primarily α-Synuclein (α-Syn), and several lines of evidence point to α-Syn as a key contributor to disease progression. Thus, basic research in the field of PD is largely focused on understanding the pathogenic properties of α-Syn. Over the past 2 y, these studies helped to identify several novel therapeutic strategies that have the potential to slow PD progression; such strategies include sequestration of extracellular α-Syn through immunotherapy, reduction of α-Syn multimerization or intracellular toxicity, and attenuation of the neuroinflammatory response. This review describes these and other putative therapeutic strategies, together with the basic science research that led to their identification. The current breadth of novel targets for the treatment of PD warrants cautious optimism in the fight against this devastating disease.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Michigan</li></region></list><tree><country name="États-Unis"><region name="Michigan"><name sortKey="Brundin, Patrik" sort="Brundin, Patrik" uniqKey="Brundin P" first="Patrik" last="Brundin">Patrik Brundin</name></region><name sortKey="Atkin, Graham" sort="Atkin, Graham" uniqKey="Atkin G" first="Graham" last="Atkin">Graham Atkin</name><name sortKey="Lamberts, Jennifer T" sort="Lamberts, Jennifer T" uniqKey="Lamberts J" first="Jennifer T" last="Lamberts">Jennifer T. Lamberts</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000310 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000310 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26177603
|texte= Basic science breaks through: New therapeutic advances in Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26177603" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |